Brainstorm Cell Therapeutics Inc.
BCLI
$1.00
$0.011.01%
OTC PK
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 22.00K | 15.00K | 29.00K | 5.00K | 824.00K |
| Total Receivables | 162.00K | 122.00K | 86.00K | 80.00K | 106.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 132.00K | 47.00K | 192.00K | 423.00K | 585.00K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 316.00K | 184.00K | 307.00K | 508.00K | 1.52M |
|
|
|||||
| Total Current Assets | 316.00K | 184.00K | 307.00K | 508.00K | 1.52M |
| Net Property, Plant & Equipment | 258.00K | 355.00K | 443.00K | 617.00K | 826.00K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | 0.00 | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 214.00K | 216.00K | 272.00K | 255.00K | 225.00K |
| Total Assets | 788.00K | 755.00K | 1.02M | 1.38M | 2.57M |
|
|
|||||
| Total Accounts Payable | 7.49M | 7.32M | 7.07M | 6.42M | 6.00M |
| Total Accrued Expenses | 454.00K | 414.00K | 396.00K | 350.00K | 367.00K |
| Short-term Debt | 1.26M | 1.33M | 967.00K | 101.00K | 101.00K |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 113.00K | 159.00K | 208.00K | 276.00K | 381.00K |
| Total Finance Division Other Current Liabilities | 3.07M | 2.55M | 2.37M | 1.88M | 1.68M |
| Total Other Current Liabilities | 3.07M | 2.55M | 2.37M | 1.88M | 1.68M |
| Total Current Liabilities | 12.39M | 11.76M | 11.01M | 9.02M | 8.53M |
|
|
|||||
| Total Current Liabilities | 12.39M | 11.76M | 11.01M | 9.02M | 8.53M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 1.26M | 1.33M | 967.00K | 101.00K | 101.00K |
| Capital Leases | -- | -- | -- | 50.00K | 95.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 12.39M | 11.76M | 11.01M | 9.07M | 8.62M |
|
|
|||||
| Common Stock & APIC | 231.44M | 228.18M | 227.07M | 226.93M | 226.46M |
| Retained Earnings | -242.93M | -239.07M | -236.94M | -234.51M | -232.40M |
| Treasury Stock & Other | -116.00K | -116.00K | -116.00K | -116.00K | -116.00K |
| Total Common Equity | -11.60M | -11.01M | -9.99M | -7.69M | -6.06M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -11.60M | -11.01M | -9.99M | -7.69M | -6.06M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -11.60M | -11.01M | -9.99M | -7.69M | -6.06M |
|
|
|||||